BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 2 hours ago Valaris Limited Drops 6.7% in Broad Selloff 3 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 4 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 4 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 4 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 5 hours ago Celanese Corporation Shares Dropping 5.5% 5 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 5 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 5 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 5 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 2 hours ago Valaris Limited Drops 6.7% in Broad Selloff 3 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 4 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 4 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 4 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 5 hours ago Celanese Corporation Shares Dropping 5.5% 5 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 5 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 5 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 5 hours ago
ADVERTISEMENT
AlphaGraphs

CME Earnings: Highlights of CME Group’s Q2 2023 report

Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023. CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth. Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. […]

July 26, 2023 1 min read

Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023. CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth. Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. […]

Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023.

CME Group Q2 2023 earnings infographic

CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth.

Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. Unadjusted earnings were $767.8 million or $2.14 per share, which is higher than the profit generated in the prior-year period.

“Given ongoing uncertainty in both macroeconomic and geopolitical environments, market participants continued turning to CME Group risk management products and services in Q2, with particularly noteworthy volume increases across our interest rate, commodity, and options contracts,” said CME’s CEO Terry Duffy.

ADVERTISEMENT